Literature DB >> 24512883

Aortic valve sclerosis as a marker of coronary artery atherosclerosis; a multicenter study of a large population with a low prevalence of coronary artery disease.

Andrea Rossi1, Nicola Gaibazzi2, Raje Dandale3, Eustachio Agricola4, Antonella Moreo5, Nicola Berlinghieri6, Daniele Sartorio2, Marco Loffi4, Benedetta De Chiara5, Fausto Rigo7, Corrado Vassanelli3, Pompilio Faggiano6.   

Abstract

UNLABELLED: There are no studies analyzing the association between aortic valve sclerosis (AVS) and coronary artery disease (CAD) in a large and multicenter patient population with an overall low prevalence of CAD. We hypothesized that AVS could predict the presence and degree of CAD in patients with severe organic mitral regurgitation.
METHODS: We retrospectively analyzed consecutive patients with flail mitral leaflet who had coronary angiography for pre-surgical screening and not because suspect of CAD. End-points were considered: 1) any degree of CAD (stenosis>20%) and 2) obstructive CAD (stenosis>75% of at least one coronary artery). AVS was defined as focal areas of increased echogenicity and thickening of the leaflets. Traditional clinical risk factors were considered: age, male gender, hypertension (>140/90 mmHg or medical therapy), hypercholesterolemia (total cholesterol>200 mg/dl or statin), diabetes, family history of CAD and smoking habit.
RESULTS: 675 patients (mean age: 64±12; 27% female) formed the study population. Among patients with AVS, 60% and 39% had any-CAD and ob-CAD respectively, on the opposite among patients without AVS 12% and 7% had any-CAD and ob-cad. After adjustment for clinical risk factors, AVS was associated with a 22.7 fold increased risk of any degree of CAD (95% CI 8.1 63.6 p<0.0001) and with a 21.8 fold increased risk of obstructive-CAD (95% CI 6.6 71.9; p<0.0001).
CONCLUSION: In a large and multicenter sample of patient with flail mitral leaflet, AVS was strongly associated with the presence and degree of CAD independently of clinical risk factors.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aortic valve sclerosis; Coronary artery disease; Organic mitral regurgitation

Mesh:

Year:  2014        PMID: 24512883     DOI: 10.1016/j.ijcard.2014.01.024

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Associations between aortic regurgitation severity and risk of incident myocardial infarction and stroke among patients with degenerative aortic valve disease: insights from a large Chinese population-based cohort study.

Authors:  Guangxiao Li; Tan Li; Yanli Chen; Xiaofan Guo; Zhao Li; Ying Zhou; Hongmei Yang; Shasha Yu; Guozhe Sun; Liqiang Zheng; Yingxian Sun
Journal:  BMJ Open       Date:  2021-08-26       Impact factor: 3.006

2.  Risk Factors for Calcific Aortic Valve Disease in Afghan Population.

Authors:  Abdul Ghafar Sherzad; Muhibullah Shinwari; M Azim Azimee; Arash Nemat; Qingchun Zeng
Journal:  Vasc Health Risk Manag       Date:  2022-08-18

3.  Risk factors for degenerative aortic valve disease in India: A case control study.

Authors:  D S Chadha; S K Malani; P Bharadwaj; G Karthikeyan; P K Hasija
Journal:  Med J Armed Forces India       Date:  2017-04-18

4.  CYP4F2 genetic polymorphisms are associated with coronary heart disease in a Chinese population.

Authors:  Changqing Yu; Qingkai Yan; Chunjiang Fu; Weibin Shi; Hongyong Wang; Chunyu Zeng; Xukai Wang
Journal:  Lipids Health Dis       Date:  2014-05-20       Impact factor: 3.876

5.  Prevalence and correlates of valvular heart diseases in the elderly population in Hubei, China.

Authors:  Chang Shu; Si Chen; Tingting Qin; Zhen Fu; Tucheng Sun; Mingxing Xie; Li Zhang; Nianguo Dong; Ping Yin
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

Review 6.  Stress Echocardiography: Need to Optimize its Appropriate Use in Suspected Angina and a Review of Available Additional Tools for its Clinical Application in 2018: First do no Harm! Second do it at the Highest Possible Accuracy.

Authors:  Nicola Gaibazzi
Journal:  J Cardiovasc Echogr       Date:  2018 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.